Ftse Mib
38.655,09
0,08%
DAX
22.551,43
0,12%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
92.759,40
-1,58%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Immunome Inc (IMNM) Immunome Inc (IMNM) Notizie

Immunome Inc

IMNM
9,40
0,51 (5,74%)
01 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/2/202514:00BWImmunome to Present at Upcoming March Conferences
06/2/202522:01BWImmunome Reports Inducement Grants Under Nasdaq Listing Rule..
04/2/202523:44EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
03/2/202523:08EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
31/1/202522:01BWImmunome Announces Closing of Upsized Public Offering and..
30/1/202522:28EDGAR2Form 8-K - Current report
30/1/202522:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/1/202505:11BWImmunome Announces Pricing of Upsized Public Offering of..
29/1/202522:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/1/202522:27BWImmunome Announces Proposed Public Offering of Common Stock
29/1/202522:03EDGAR2Form 8-K - Current report
23/1/202522:01EDGAR2Form 8-K - Current report
13/1/202514:00BWImmunome Provides Pipeline Update in Advance of Presentation..
07/1/202514:00GLOBEHummingbird Bioscience Licenses Novel Antibodies to Immunome
03/1/202500:03BWImmunome Reports Inducement Grants Under Nasdaq Listing Rule..
03/12/202400:26BWImmunome Reports Inducement Grants Under Nasdaq Listing Rule..
27/11/202414:00BWImmunome to Present at the Piper Sandler 36th Annual..
25/11/202414:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202414:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
14/11/202419:28EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202422:06EDGAR2Form 8-K - Current report
13/11/202422:05BWImmunome Reports Third Quarter 2024 Financial Results and..
05/11/202414:00BWImmunome to Present at Guggenheim’s Inaugural Healthcare..
01/11/202421:05BWImmunome Reports Inducement Grants Under Nasdaq Listing Rule..
29/10/202413:05EDGAR2Form 8-K - Current report
29/10/202413:00BWImmunome Presents Compelling Preclinical Data Demonstrating..
18/10/202414:00BWImmunome to Present Poster Highlighting Preclinical..
08/10/202422:31EDGAR2Form S-3ASR - Automatic shelf registration statement of..
08/10/202414:05BWImmunome Appoints Roee Shahar as Executive Vice President,..
08/10/202414:00BWImmunome Reports Inducement Grants Under Nasdaq Listing Rule..
21/9/202401:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202420:18EDGAR2Form 144 - Report of proposed sale of securities
13/9/202413:00BWImmunome to Present Updated Results for RINGSIDE Phase 2..
29/8/202414:00BWImmunome to Present at Morgan Stanley 22nd Annual Global..
21/8/202422:05EDGAR2Form SC 13D/A - General Statement of Acquisition of..
20/8/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202421:21EDGAR2Form 144 - Report of proposed sale of securities
13/8/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:05EDGAR2Form 8-K - Current report
12/8/202422:01BWImmunome Reports Second Quarter 2024 Financial Results and..
25/7/202414:00BWImmunome Provides Update on Recent Business Development..
27/6/202414:00BWImmunome Appoints Phil Tsai as Chief Technical Officer
Apertura: 8,70 Min: 8,55 Max: 9,44
Chiusura: 8,89

La tua Cronologia

NASDAQ
IMNM
Immunome
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci